Back to search

Article

Design of SARS-CoV-2 RBD mRNA Vaccine Using Novel Ionizable Lipids

2020-10-15

Abstract excerpt

The novel coronavirus SARS-CoV-2 has been identified as the causal agent of COVID-19 and stands at the center of the current global human pandemic, with death toll exceeding one million. The urgent need for a vaccine has led to the development of various immunization approaches. mRNA vaccines represent a cell-free, simple and rapid platform for immunization, and therefore have been employed in recent studies towar...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
98441f41-55cd-51e1-865b-d682efe0f44e
DOI
10.1101/2020.10.15.341537
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Design of SARS-CoV-2 RBD mRNA Vaccine Using Novel Ionizable LipidsDOI 10.1101/2020.10.15.341537
Delivery of Circular mRNA via Degradable Lipid Nanoparticles against SARS-CoV-2 Delta VariantSemantic proximity
Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its VariantsSemantic proximity
Rational development of a combined mRNA vaccine against COVID-19 and influenzaSemantic proximity
An Update on mRNA-Based Viral VaccinesSemantic proximity
Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines: The Superiority of Nucleoside-Modified mRNA Encapsulated in Lipid Nanoparticles Vaccine PlatformSemantic proximity
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based TherapeuticsSemantic proximity
The Delivery of mRNA Vaccines for TherapeuticsSemantic proximity
The Preclinical Evaluation of Self-Replicating RNA Oral Vaccine to Simultaneously Neutralize Both SARS-CoV-2 Delta and Alpha VariantsSemantic proximity
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-BSemantic proximity
Lipid nanoparticles in the development of mRNA vaccines for COVID-19Semantic proximity
An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine DevelopmentSemantic proximity
An mRNA vaccine against SARS-CoV-2: Lyophilized, liposome-based vaccine candidate EG-COVID induces high levels of virus neutralizing antibodiesSemantic proximity
Select a neighboring publication to make it the new centre.